SG10201604810UA - Compartmentalized method of nucleic acid delivery and compositions and uses thereof - Google Patents
Compartmentalized method of nucleic acid delivery and compositions and uses thereofInfo
- Publication number
- SG10201604810UA SG10201604810UA SG10201604810UA SG10201604810UA SG10201604810UA SG 10201604810U A SG10201604810U A SG 10201604810UA SG 10201604810U A SG10201604810U A SG 10201604810UA SG 10201604810U A SG10201604810U A SG 10201604810UA SG 10201604810U A SG10201604810U A SG 10201604810UA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- nucleic acid
- acid delivery
- compartmentalized method
- compartmentalized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1071—Liver; Hepar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261633287P | 2012-02-07 | 2012-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201604810UA true SG10201604810UA (en) | 2016-08-30 |
Family
ID=47750057
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201604810UA SG10201604810UA (en) | 2012-02-07 | 2013-02-07 | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| SG11201404741VA SG11201404741VA (en) | 2012-02-07 | 2013-02-07 | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| SG10201609345QA SG10201609345QA (en) | 2012-02-07 | 2013-02-07 | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404741VA SG11201404741VA (en) | 2012-02-07 | 2013-02-07 | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| SG10201609345QA SG10201609345QA (en) | 2012-02-07 | 2013-02-07 | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9821114B2 (en) |
| EP (2) | EP3970734A3 (en) |
| JP (2) | JP6188728B2 (en) |
| KR (1) | KR102063195B1 (en) |
| CN (3) | CN107982548A (en) |
| AU (1) | AU2013216920B2 (en) |
| BR (1) | BR112014019431A8 (en) |
| CA (1) | CA2863964C (en) |
| EA (1) | EA033803B1 (en) |
| HK (1) | HK1204770A1 (en) |
| IL (1) | IL233946B (en) |
| MX (1) | MX367842B (en) |
| NZ (2) | NZ715957A (en) |
| SG (3) | SG10201604810UA (en) |
| WO (1) | WO2013119880A1 (en) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100183558A1 (en) | 2008-10-17 | 2010-07-22 | Zhennan Lai | Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
| NZ715957A (en) | 2012-02-07 | 2017-08-25 | Global Bio Therapeutics Inc | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
| US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| CA2874316A1 (en) * | 2012-05-03 | 2013-11-07 | Indiana University Research And Technology Corporation | Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods |
| CA3209821A1 (en) * | 2013-05-15 | 2014-11-20 | Regents Of The University Of Minnesota | Adeno-associated virus mediated gene transfer to the central nervous system |
| ES2647789T3 (en) | 2013-08-08 | 2017-12-26 | Global Bio Therapeutics, Inc. | Injection device for minimally invasive procedures |
| JP6297692B2 (en) | 2013-08-08 | 2018-03-20 | グローバル・バイオ・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Clamp device for minimally invasive treatment and use thereof |
| EP3039138A4 (en) | 2013-08-30 | 2017-04-26 | Indiana University Research and Technology Corporation | Hydrodynamic method and apparatus for delivering fluids to kidney tissues |
| US10219492B2 (en) * | 2013-11-22 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Compounds and methods for altering RSV replication rate |
| CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
| KR20220100728A (en) * | 2014-03-21 | 2022-07-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Genome editing without nucleases |
| CA2946392A1 (en) * | 2014-04-25 | 2015-10-29 | James M. Wilson | Ldlr variants and their use in compositions for reducing cholesterol levels |
| AU2015259362B2 (en) * | 2014-05-12 | 2018-02-15 | The Johns Hopkins University | Engineering synthetic brain penetrating gene vectors |
| DE102015201100B4 (en) * | 2015-01-22 | 2018-05-17 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Antiviral agent |
| US10688285B2 (en) | 2015-01-30 | 2020-06-23 | The Regents Of The University Of California | Spinal subpial gene delivery system |
| JP2018506530A (en) * | 2015-01-30 | 2018-03-08 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Spinal subpuffy gene delivery system |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| JP7065036B2 (en) | 2015-12-17 | 2022-05-11 | モダーナティエックス・インコーポレイテッド | Polynucleotide encoding methylmalonyl CoA mutase |
| EP3402483B1 (en) | 2016-01-15 | 2023-11-08 | American Gene Technologies International Inc. | Methods and compositons for the activation of gamma-delta t-cells |
| US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
| CN109477119A (en) * | 2016-02-04 | 2019-03-15 | 斯比根公司 | Express the mescenchymal stem cell and application thereof of hepatocyte growth factor |
| EP3413926A4 (en) | 2016-02-08 | 2019-10-09 | American Gene Technologies International, Inc. | Hiv vaccination and immunotherapy |
| ES2911448T3 (en) | 2016-03-09 | 2022-05-19 | American Gene Tech Int Inc | Combined Vectors and Methods for Cancer Treatment |
| CA3018960C (en) | 2016-03-28 | 2023-09-26 | The Regents Of The University Of California | Method and composition for treating neuronal hyper-excitability |
| US11253612B2 (en) | 2016-04-15 | 2022-02-22 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type II |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| EP3458108A4 (en) | 2016-05-18 | 2020-04-22 | ModernaTX, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| CA3024507A1 (en) | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | Polynucleotides encoding .alpha.-galactosidase a for the treatment of fabry disease |
| US11045557B2 (en) | 2016-06-09 | 2021-06-29 | Queen's University At Kingston | Methods and gene therapy constructs for treating GM2 gangliosidoses |
| WO2018009246A1 (en) | 2016-07-08 | 2018-01-11 | American Gene Technologies International Inc. | Hiv pre-immunization and immunotherapy |
| JP7176756B2 (en) | 2016-07-21 | 2022-11-22 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | Viral vectors for treating Parkinson's disease |
| KR101671361B1 (en) * | 2016-08-08 | 2016-11-01 | 에스씨엠생명과학 주식회사 | Pharmaceutical composition for preventing or treating hair loss comprising TYMP(thymidine phosphorylase) protein |
| US11266344B2 (en) | 2016-09-21 | 2022-03-08 | Samsung Electronics Co., Ltd. | Method for measuring skin condition and electronic device therefor |
| CN109863243B (en) * | 2016-09-30 | 2023-07-28 | 埃斯蒂文制药股份有限公司 | Adeno-associated viral vectors for the treatment of mucopolysaccharidoses |
| CN110494543A (en) | 2016-10-19 | 2019-11-22 | 弗洛设计声能学公司 | Pass through the affine cell extraction of acoustics |
| JP2020512815A (en) * | 2017-04-03 | 2020-04-30 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | Compositions and methods for treating phenylketonuria |
| WO2019039863A2 (en) * | 2017-08-23 | 2019-02-28 | 주식회사 압타머사이언스 | Method for preparing aptamer using surrogate virus |
| CA3074587A1 (en) | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | Method and composition for treating neuropathic pain |
| SG11202002457RA (en) | 2017-09-22 | 2020-04-29 | Univ Pennsylvania | Gene therapy for treating mucopolysaccharidosis type ii |
| CA3077355A1 (en) * | 2017-10-02 | 2019-04-11 | American Gene Technologies International Inc. | Vectors with promoter and enhancer combinations for treating phenylketonuria |
| US11859215B2 (en) | 2017-11-22 | 2024-01-02 | Modernatx, Inc. | Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders |
| AU2018385759B2 (en) | 2017-12-14 | 2021-10-21 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
| JP7140353B2 (en) | 2017-12-29 | 2022-09-22 | ヘリックスミス カンパニー， リミテッド | AAV (adeno-associated virus) vector into which the hybrid HGF gene has been introduced |
| CA3093716A1 (en) * | 2018-03-16 | 2019-09-19 | Immusoft Corporation | B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength |
| CN108576402A (en) * | 2018-03-22 | 2018-09-28 | 昆明三正生物科技（集团）有限公司 | A kind of suckling piglet specific enzyme production method |
| CA3103963A1 (en) * | 2018-07-02 | 2020-01-09 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
| US20220333135A1 (en) * | 2018-07-16 | 2022-10-20 | Baxalta Incorporated | Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression |
| SG11202101819QA (en) * | 2018-08-30 | 2021-03-30 | Res Inst Nationwide Childrens Hospital | Gene therapy for the treatment of galactosemia |
| CN109504709B (en) * | 2018-11-28 | 2020-07-24 | 上海安民生物技术有限公司 | Albumin expression vector driven by albumin promoter |
| EP3908198A4 (en) | 2019-01-10 | 2022-09-14 | The Regents of the University of California | Subpial delivery system and methods of use |
| CN110272810A (en) * | 2019-07-01 | 2019-09-24 | 广州世赛生物科技有限公司 | Allogenic material is delivered to device and method and its application in eukaryocyte |
| EP4073106A2 (en) * | 2019-12-12 | 2022-10-19 | Takeda Pharmaceutical Company Limited | Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression |
| USD963164S1 (en) | 2020-01-09 | 2022-09-06 | The Regents Of The University Of California | Surgical needle |
| WO2021154414A2 (en) | 2020-01-29 | 2021-08-05 | Catalyst Biosciences, Inc. | Gene therapy for hemophilia b with a chimeric aav capsid vector encoding modified factor ix polypeptides |
| CN114786683B (en) * | 2021-04-09 | 2024-01-12 | 北京大学 | siRNA, pharmaceutical composition and method for treating diabetes by using siRNA and pharmaceutical composition |
| CN115074344B (en) * | 2022-06-24 | 2023-09-19 | 徐州医科大学 | Multi-level strict regulation suicide protein rCas8 activity system and application thereof |
Family Cites Families (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US567048A (en) | 1896-09-01 | Wedge for filling and tightening wood joints | ||
| US3667471A (en) | 1969-08-15 | 1972-06-06 | Us Army | Surgical clamp |
| US4652525A (en) | 1978-04-19 | 1987-03-24 | The Regents Of The University Of California | Recombinant bacterial plasmids containing the coding sequences of insulin genes |
| US4342832A (en) | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
| US4431740A (en) | 1979-09-12 | 1984-02-14 | The Regents Of The University Of California | DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes |
| US4328803B1 (en) | 1980-10-20 | 1994-01-11 | Opthalmic Systems, Inc. | Opthalmological procedures |
| EP0091539B2 (en) | 1982-03-31 | 1996-11-27 | Ajinomoto Co., Inc. | Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4517295A (en) | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| US6696420B1 (en) | 1984-11-20 | 2004-02-24 | Institut Pasteur | Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein |
| FR2573436B1 (en) | 1984-11-20 | 1989-02-17 | Pasteur Institut | RECOMBINANT DNA COMPRISING A NUCLEOTIDE SEQUENCE ENCODING A DETERMINED POLYPEPTIDE UNDER THE CONTROL OF AN ADENOVIRUS PROMOTER, VECTORS CONTAINING THIS RECOMBINANT DNA, EUKARYOT CELLS TRANSFORMED BY THIS RECOMBINANT DNA, THE CONSTITUTION OF VACCINES |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| EP0275598B1 (en) | 1986-12-16 | 1998-01-07 | Gist-Brocades N.V. | Molecular cloning and expression of human IL-3 |
| OA09736A (en) | 1987-02-18 | 1993-11-30 | Schering Biotech Corp | "Human interleukin-3 and muteins thereof". |
| US5282851A (en) | 1987-07-07 | 1994-02-01 | Jacob Labarre Jean | Intraocular prostheses |
| US4965195A (en) | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
| US5229127A (en) | 1989-03-03 | 1993-07-20 | Mckinzie James W | Rapid miosis with control of intraocular pressure using a mixture of a cetylcholine and carbachol derivatives |
| US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5670488A (en) | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| US5292362A (en) | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
| JPH06502078A (en) * | 1990-12-03 | 1994-03-10 | アメリカ合衆国 | Increased muscle tissue in animals |
| US5203786A (en) | 1991-06-19 | 1993-04-20 | Thomas Jefferson University | Hepatic resection clamp |
| JPH07503372A (en) | 1992-01-23 | 1995-04-13 | バイカル・インコーポレイテッド | In vitro gene transfer |
| US5273056A (en) | 1992-06-12 | 1993-12-28 | Alcon Laboratories, Inc. | Use of combinations of viscoelastics during surgery |
| US5846945A (en) | 1993-02-16 | 1998-12-08 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| JPH08511423A (en) * | 1993-06-10 | 1996-12-03 | ジェネティック セラピー，インコーポレイテッド | Adenovirus vector for treatment of hemophilia |
| US5919676A (en) | 1993-06-24 | 1999-07-06 | Advec, Inc. | Adenoviral vector system comprising Cre-loxP recombination |
| US5543328A (en) | 1993-08-13 | 1996-08-06 | Genetic Therapy, Inc. | Adenoviruses having modified fiber proteins |
| WO1995026411A2 (en) | 1994-03-25 | 1995-10-05 | The Uab Research Foundation | Composition and methods for creating syngeneic recombinant virus-producing cells |
| EP0763103A4 (en) | 1994-04-28 | 1998-07-15 | Univ Michigan | Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
| EP1548118A2 (en) | 1994-06-10 | 2005-06-29 | Genvec, Inc. | Complementary adenoviral vector systems and cell lines |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| BR9508910A (en) | 1994-09-12 | 1997-10-28 | Schering Ag | Process for manufacturing a modified collagen-induced platelet aggregation inhibitor pallidipine |
| US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
| US5792453A (en) | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
| US5869230A (en) | 1995-03-30 | 1999-02-09 | Beth Israel Hospital Association | Gene transfer into the kidney |
| ATE278794T1 (en) | 1995-06-15 | 2004-10-15 | Crucell Holland Bv | PACKAGING SYSTEMS FOR HUMAN, HUMAN ADENOVIRUSES, FOR USE IN GENE THERAPY |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US5622856A (en) | 1995-08-03 | 1997-04-22 | Avigen | High efficiency helper system for AAV vector production |
| US20020001574A1 (en) * | 1995-12-13 | 2002-01-03 | Jon A. Woiff | Process of delivering a polynucleotide to a muscle cell via the vascular system |
| US20010009904A1 (en) * | 1997-12-30 | 2001-07-26 | Jon A. Wolff | Process of delivering a polynucleotide to a cell via the vascular system |
| DE19600328C1 (en) | 1996-01-08 | 1997-02-13 | Zimmermann Jos Gmbh & Co Kg | Tufting needles for a needle module |
| US6121247A (en) * | 1996-03-29 | 2000-09-19 | The Johns Hopkins University | Therapy for allergic diseases |
| DE19620687A1 (en) * | 1996-05-22 | 1997-11-27 | Centeon Pharma Gmbh | New adenoviral vector for the transfer of human genes in vivo |
| US5785689A (en) | 1996-07-18 | 1998-07-28 | Act Medical, Inc. | Endoscopic catheter sheath position control |
| EP0941122B1 (en) | 1996-08-13 | 2003-10-29 | Chiron Corporation | Compositions for polynucleotide delivery |
| US5704908A (en) | 1996-10-10 | 1998-01-06 | Genetronics, Inc. | Electroporation and iontophoresis catheter with porous balloon |
| US20080305999A1 (en) | 1996-11-01 | 2008-12-11 | John Francis Martin | Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| US6891082B2 (en) | 1997-08-01 | 2005-05-10 | The Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a truncated activintype II receptor |
| US6183444B1 (en) | 1998-05-16 | 2001-02-06 | Microheart, Inc. | Drug delivery module |
| EP1049487B1 (en) | 1998-01-27 | 2002-05-22 | Hemebiotech A/S | Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| US5997509A (en) | 1998-03-06 | 1999-12-07 | Cornell Research Foundation, Inc. | Minimally invasive gene therapy delivery device and method |
| AU756562B2 (en) | 1998-05-21 | 2003-01-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Method for pressure mediated selective delivery of therapeutic substances and cannula |
| AU4219399A (en) | 1998-06-08 | 1999-12-30 | Valentis, Inc. | Formulations for electroporation |
| WO2000009675A1 (en) | 1998-08-14 | 2000-02-24 | Aventis Pharmaceuticals Products Inc. | Adenovirus formulations for gene therapy |
| CA2349760C (en) | 1998-11-02 | 2012-02-21 | University Of Saskatchewan | Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| GB9824437D0 (en) | 1998-11-06 | 1999-01-06 | Ylo Herttuala Seppo | Gene therapy |
| DE19956568A1 (en) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Method and medicament for inhibiting the expression of a given gene |
| CA2370081C (en) | 1999-06-24 | 2014-06-03 | The University Of British Columbia | Lpl variant therapeutics |
| CA2386270A1 (en) | 1999-10-15 | 2001-04-26 | University Of Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US7329728B1 (en) | 1999-10-25 | 2008-02-12 | The Scripps Research Institute | Ligand activated transcriptional regulator proteins |
| US6218186B1 (en) | 1999-11-12 | 2001-04-17 | Trustees Of The University Of Pennsylvania | HIV-MSCV hybrid viral vector for gene transfer |
| ES2336887T5 (en) | 2000-03-30 | 2019-03-06 | Whitehead Inst Biomedical Res | Mediators of RNA interference specific to RNA sequences |
| GB0013105D0 (en) * | 2000-05-30 | 2000-07-19 | Univ Bristol | Therapeutic compounds |
| US20100305186A1 (en) | 2000-05-30 | 2010-12-02 | Johnson & Johnson Research Pty Limited | Methods for mediating gene suppression |
| US7011972B2 (en) | 2000-07-18 | 2006-03-14 | The Scripps Research Institute | Fusion polypeptide comprising two ligand binding domains |
| US6821264B1 (en) | 2000-11-27 | 2004-11-23 | Gautam Khurana | Gene delivery device and gene delivery method |
| IL152420A0 (en) | 2001-02-23 | 2003-05-29 | Novartis Ag | Novel oncolytic adenoviral vectors |
| US20040009151A1 (en) | 2002-04-04 | 2004-01-15 | Kay Mark A. | Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal |
| AU2003274397A1 (en) | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| JP2006501177A (en) * | 2002-06-24 | 2006-01-12 | ジェンザイム・コーポレイション | Methods for delivering gene therapy drugs |
| JP5051679B2 (en) | 2003-08-29 | 2012-10-17 | 日本パーカライジング株式会社 | Alkali cleaning method for aluminum or aluminum alloy DI can |
| WO2005049094A1 (en) | 2003-11-13 | 2005-06-02 | Advantagene, Inc. | A mixed complementary viral vector for gene therapy |
| US20050129660A1 (en) | 2003-12-11 | 2005-06-16 | Hagstrom James E. | Process of delivering a virally encapsulated polynucleotide or viral vector to a parenchymal cell via the vascular system |
| WO2005060746A1 (en) * | 2003-12-11 | 2005-07-07 | Mirus Corporation | Delivery of viral vectors to extravascular parenchymal cells |
| GB0406728D0 (en) * | 2004-03-25 | 2004-04-28 | Hydrodynamic Gene Delivery Ltd | Gene therapy |
| US7645285B2 (en) | 2004-05-26 | 2010-01-12 | Idx Medical, Ltd | Apparatus and methods for occluding a hollow anatomical structure |
| BRPI0515819A (en) | 2004-12-01 | 2008-08-05 | Genzyme Corp | methods for targeted delivery of genetic material to the liver |
| CA2592699C (en) | 2004-12-31 | 2023-02-21 | Per Sonne Holm | Method for reversing multiple resistance in animal cells |
| US8092464B2 (en) | 2005-04-30 | 2012-01-10 | Warsaw Orthopedic, Inc. | Syringe devices and methods useful for delivering osteogenic material |
| EP1928504B1 (en) | 2005-08-19 | 2013-04-24 | University of Technology, Sydney | Liver-directed gene therapy |
| US20100316609A1 (en) * | 2006-10-18 | 2010-12-16 | University Of Rochester | Conditionally Replicating Viruses for Cancer Therapy |
| WO2008049246A2 (en) | 2006-10-25 | 2008-05-02 | Pi-Design Ag | Electric milk frothing apparatus |
| US20080119880A1 (en) | 2006-11-16 | 2008-05-22 | Chu David Z J | Laparoscopic surgical clamp |
| US8398576B2 (en) * | 2007-04-02 | 2013-03-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Removal of contrast agents from blood |
| WO2009038462A1 (en) | 2007-09-19 | 2009-03-26 | Amsterdam Molecular Therapeutics B.V. | Use of aav replication machinery for improved protein production |
| EP2068294A1 (en) | 2007-12-03 | 2009-06-10 | Endosim Limited | Laparoscopic training apparatus |
| US20100234862A1 (en) | 2007-12-06 | 2010-09-16 | Manoj Patel | Surgical clamp and method of clamping an organ |
| WO2010036118A1 (en) | 2008-09-29 | 2010-04-01 | Amsterdam Molecular Therapeutics (Amt) B.V. | Porphobilinogen deaminase gene therapy |
| ES2634118T3 (en) | 2009-02-11 | 2017-09-26 | The University Of North Carolina At Chapel Hill | Modified virus vectors and methods to manufacture and use them |
| US20110305772A1 (en) | 2009-02-26 | 2011-12-15 | The Johns Hopkins University | Compositions and methods for ex vivo hepatic nucleic acid delivery |
| WO2010134806A1 (en) | 2009-05-18 | 2010-11-25 | Amsterdam Molecular Therapeutics (Amt) Ip B.V. | Use of lipoprotein lipase (lpl) in therapy |
| NZ715957A (en) | 2012-02-07 | 2017-08-25 | Global Bio Therapeutics Inc | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
| ES2647789T3 (en) | 2013-08-08 | 2017-12-26 | Global Bio Therapeutics, Inc. | Injection device for minimally invasive procedures |
| JP6297692B2 (en) | 2013-08-08 | 2018-03-20 | グローバル・バイオ・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Clamp device for minimally invasive treatment and use thereof |
-
2013
- 2013-02-07 NZ NZ715957A patent/NZ715957A/en not_active IP Right Cessation
- 2013-02-07 EP EP21167237.3A patent/EP3970734A3/en not_active Withdrawn
- 2013-02-07 MX MX2014009480A patent/MX367842B/en active IP Right Grant
- 2013-02-07 SG SG10201604810UA patent/SG10201604810UA/en unknown
- 2013-02-07 SG SG11201404741VA patent/SG11201404741VA/en unknown
- 2013-02-07 CA CA2863964A patent/CA2863964C/en active Active
- 2013-02-07 CN CN201711235370.3A patent/CN107982548A/en active Pending
- 2013-02-07 EA EA201400871A patent/EA033803B1/en not_active IP Right Cessation
- 2013-02-07 BR BR112014019431A patent/BR112014019431A8/en not_active IP Right Cessation
- 2013-02-07 WO PCT/US2013/025234 patent/WO2013119880A1/en active Application Filing
- 2013-02-07 KR KR1020147025109A patent/KR102063195B1/en active IP Right Grant
- 2013-02-07 CN CN201910870752.6A patent/CN110917362A/en active Pending
- 2013-02-07 SG SG10201609345QA patent/SG10201609345QA/en unknown
- 2013-02-07 NZ NZ627992A patent/NZ627992A/en not_active IP Right Cessation
- 2013-02-07 CN CN201380018970.8A patent/CN104428009A/en active Pending
- 2013-02-07 EP EP13706130.5A patent/EP2812012A1/en not_active Withdrawn
- 2013-02-07 AU AU2013216920A patent/AU2013216920B2/en not_active Ceased
- 2013-02-07 US US13/815,206 patent/US9821114B2/en active Active
- 2013-02-07 JP JP2014556699A patent/JP6188728B2/en not_active Expired - Fee Related
-
2014
- 2014-08-04 IL IL233946A patent/IL233946B/en not_active IP Right Cessation
-
2015
- 2015-06-04 HK HK15105338.3A patent/HK1204770A1/en unknown
-
2017
- 2017-08-01 JP JP2017149223A patent/JP6463421B2/en not_active Expired - Fee Related
- 2017-11-06 US US15/804,960 patent/US20180055997A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1204770A1 (en) | Compartmentalized method of nucleic acid delivery and compositions and uses thereof | |
| IL281295A (en) | Compositions and methods for inhibiting expression of the alas1 gene | |
| HK1247254A1 (en) | Methods and compositions for nucleic acid sequencing | |
| HRP20181448T1 (en) | Anthelmintic compounds and compositions and method of using thereof | |
| EP2844755A4 (en) | Methods and compositions for extraction and storage of nucleic acids | |
| HK1209621A1 (en) | Inhibitors of the mir-15 family of micro-rnas mir-15 rna | |
| HK1216503A1 (en) | Compositions and methods for transdermal delivery of amphetamine | |
| HK1217518A1 (en) | Compositions and methods of nucleic acid preparation and analyses | |
| EP2877028A4 (en) | Compositions and method of controlling phytoparasitic pest populations | |
| IL226170B (en) | Compositions and methods for nanopolymer-based nucleic acid delivery | |
| EP2894964A4 (en) | Compositions and method of controlling fungus | |
| EP2880166A4 (en) | Compositions and methods for genetic constructs | |
| IL234964A0 (en) | Methods and compositions for dual extraction of protein and nucleic acid | |
| IL233445A0 (en) | Methods and compositions for gene delivery | |
| EP2808019A4 (en) | Improved nitazoxanide composition and preparation method thereof |